Myelofibrosis: Difference between revisions
No edit summary |
No edit summary |
||
| Line 27: | Line 27: | ||
==[[Myelofibrosis risk factors|Risk Factors]]== | ==[[Myelofibrosis risk factors|Risk Factors]]== | ||
==[[Myelofibrosis screening|Screening]]== | |||
==[[Myelofibrosis natural history|Natural History, Complications and Prognosis]]== | ==[[Myelofibrosis natural history|Natural History, Complications and Prognosis]]== | ||
Revision as of 14:38, 10 March 2016
For patient information, click here
Template:DiseaseDisorder infobox
|
Myelofibrosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Myelofibrosis On the Web |
|
American Roentgen Ray Society Images of Myelofibrosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2], Sujit Routray, M.D. [3]
Synonyms and keywords: Agnogenic myeloid metaplasia; AMM; Myeloid metaplasia; Myelofibrosis with myeloid metaplasia; MMM; Assmann's disease; Chronic idiopathic myelofibrosis; CIMF; Heuck-Assmann disease; Idiopathic myelofibrosis; Primary myelofibrosis; PMF; Secondary myelofibrosis; Myelosclerosis; Osteomyelofibrosis; Osteomyelosclerosis; Myeloproliferative disorder
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Myelofibrosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria | Staging | History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI | Bone Marrow Biopsy | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies